<code id='BA1D711B73'></code><style id='BA1D711B73'></style>
    • <acronym id='BA1D711B73'></acronym>
      <center id='BA1D711B73'><center id='BA1D711B73'><tfoot id='BA1D711B73'></tfoot></center><abbr id='BA1D711B73'><dir id='BA1D711B73'><tfoot id='BA1D711B73'></tfoot><noframes id='BA1D711B73'>

    • <optgroup id='BA1D711B73'><strike id='BA1D711B73'><sup id='BA1D711B73'></sup></strike><code id='BA1D711B73'></code></optgroup>
        1. <b id='BA1D711B73'><label id='BA1D711B73'><select id='BA1D711B73'><dt id='BA1D711B73'><span id='BA1D711B73'></span></dt></select></label></b><u id='BA1D711B73'></u>
          <i id='BA1D711B73'><strike id='BA1D711B73'><tt id='BA1D711B73'><pre id='BA1D711B73'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:614
          Illustration of a hospital being handed from a doctor to a business person – politics and policy coverage from STAT
          New guidelines from federal antitrust enforcers would have big implications on health care deals. Adobe

          Health care companies trying to merge can expect tougher policing from the top federal antitrust agencies, according to a set of new draft guidelines released Wednesday.

          The Department of Justice and Federal Trade Commission laid out 13 proposed guidelines detailing how they will judge whether proposed mergers and acquisitions are anticompetitive and should be challenged.

          advertisement

          The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly. Research has shown that health care’s highly concentrated markets are a major reason why prices and spending have soared for patients and taxpayers.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Readout Newsletter: XBI biotech index, Akero Therapeutics
          Readout Newsletter: XBI biotech index, Akero Therapeutics

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

          OutgoingBristolCEOGiovanniCaforioEmiliePickeringforSTATIt’schangingoftheguardtimeatpharmaceuticalgia